EUVIMEDEUVIMED entdecken
Crossref

Achyranthes Bidentata Root Extract Alleviates Rosiglitazone Induced Bone Loss in Diabetic Rats

Ali Alqahtani, Khalid A Asseri, Yahya I Asiri, Krishnaraju Venkatesan, Noohu Abdulla Khan, Sirajudeen Shaik Alavudeen, Ester Mary Pappiya, Premalatha Paulsamy, R. Natarajan, Kalpana Krishnaraju, Kumarappan Chidambaram, Kumar Venkatesan

IAR Journal of Pharmacy · 10.09.2021 · 2 (2) · 1-4

DOI: 10.47310/iarjp.2021.v02i02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IAR Journal of Pharmacy, online erschienen am 10.09.2021. Verfasst von Ali Alqahtani und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, diabetes mellitus has been linked to an increased risk of osteoporosis-related fractures and osteoarthritis. ABRE (Achyranthes Bidentata Root Extract) has previously been shown to prevent bone damage. However, it is unknown whether ABRE can protect diabetics from developing bone loss when co-treated with Rosiglitazone. This study looks at the effects of ABRE on bone oxidative stress and turnover markers in diabetic rats. Streptozotocin (STZ) causes diabetics. Five groups of six Wistar albino rats were studied: control (vehicle therapy), Streptozotocin (diabetes) group, ABRE group, Rosiglitazone and Rosiglitazone + ABRE group. Each medicine was given by gastric gavage once a day for 35 days. A healthy rat group was used as a standard control group. Insulin, oxidative stress and bone turnover markers were measured in the blood using ELISA assays. Diabetic rats given ABRE had significantly greater insulin and osteocalcin levels than diabetic control rats. ABRE may be able to prevent diabetic osteoporosis by boosting osteogenesis and lowering bone oxidative stress. These findings support the use of ABRE as a diabetic osteoporosis therapy.

Zitieren

APA

Alqahtani, A., Asseri, K. A., Asiri, Y. I., Venkatesan, K., Khan, N. A., Alavudeen, S. S., Pappiya, E. M., Paulsamy, P., Natarajan, R., Krishnaraju, K., Chidambaram, K., & Venkatesan, K. (2021). Achyranthes Bidentata Root Extract Alleviates Rosiglitazone Induced Bone Loss in Diabetic Rats. IAR Journal of Pharmacy, 2(2), 1-4. https://doi.org/10.47310/iarjp.2021.v02i02.009

Vancouver

Alqahtani A, Asseri KA, Asiri YI, Venkatesan K, Khan NA, Alavudeen SS, et al. Achyranthes Bidentata Root Extract Alleviates Rosiglitazone Induced Bone Loss in Diabetic Rats. IAR Journal of Pharmacy. 2021;2(2):1-4. doi:10.47310/iarjp.2021.v02i02.009

BibTeX
@article{Alqahtani2021,
  author = {Alqahtani, Ali and Asseri, Khalid A and Asiri, Yahya I and Venkatesan, Krishnaraju and Khan, Noohu Abdulla and Alavudeen, Sirajudeen Shaik and Pappiya, Ester Mary and Paulsamy, Premalatha and Natarajan, R. and Krishnaraju, Kalpana and Chidambaram, Kumarappan and Venkatesan, Kumar},
  title = {Achyranthes Bidentata Root Extract Alleviates Rosiglitazone Induced Bone Loss in Diabetic Rats},
  journal = {IAR Journal of Pharmacy},
  year = {2021},
  volume = {2},
  number = {2},
  pages = {1--4},
  doi = {10.47310/iarjp.2021.v02i02.009}
}
Kostenlos starten →